Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.IJROBP.2005.05.034PMID 16169670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment planning of stereotactic radiotherapy for solitary lung tumor.

  2005cited by this paper
• Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.

  2004cited by this paper
• Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma

  2004cited by this paper
• 18F-FDG and11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy

  2004cited by this paper
• Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance.

  2004cited by this paper
• Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.

  2003cited by this paper
• Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.

  2003cited by this paper
• The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy.

  2001cited by this paper
• Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience.

  2001cited by this paper
• Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame.

  2001cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• Radiosurgery for Tumors in the Body: Clinical Experience Using a New Method

  1998cited by this paper
• Extracranial Stereotactic Radiosurgery of Localized Targets

  1998cited by this paper
• 2175 Radiosurgery for tumors in the body

  1997cited by this paper
• Predicting radiation response.

  1997cited by this paper
• Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

  1995cited by this paper
• On using the linear-quadratic model in daily clinical practice.

  1991cited by this paper

• Exploring the feasibility of millimeter-wave sensors for non-invasive respiratory motion visualization in diagnostic imaging and therapy.

  2025cites this paper
• Risk factors for radiation-induced rib fractures following proton beam therapy for stage I non-small cell lung cancer: a retrospective study

  2025cites this paper
• Targeted therapy acts to sensitize stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer

  2025cites this paper
• Proton stereotactic body radiotherapy for early‐stage non‐small cell lung cancer: Influence of case‐specific characteristics on dosimetric robustness

  2025cites this paper
• Stereotactic body radiotherapy for lung cancer: a review.

  2025cites this paper
• What is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (≥ 5 cm) Non-Small Cell Lung Cancer?

  2025cites this paper
• Long-term outcomes of combination therapy with stereotactic body radiation therapy plus cryoablation using liquid nitrogen for stage I non-small cell lung cancer with tumors ≥2 cm

  2025influential citation
• Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC) Therapy

  2024cites this paper
• Dose Prescription to Isodose Lines in Static Multi-Beam Stereotactic Body Radiotherapy for Lung Tumors: Which Line Is Optimal?

  2024cites this paper
• Dosimetric evaluation in Helical TomoTherapy for lung SBRT using Monte Carlo‐based independent dose verification software

  2024cites this paper
• Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial.

  2024cites this paper
• Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy

  2024cites this paper
• Mathematical model combined with microdosimetric kinetic model for tumor volume calculation in stereotactic body radiation therapy

  2023cites this paper
• Physical and biological dosimetric margin according to prescription method for stereotactic body radiation therapy

  2023cites this paper
• Tumor Hypoxia and Radiotherapy: A Major Driver of Resistance Even for Novel Radiotherapy Modalities.

  2023cites this paper
• Radiotherapy for Lung Metastases: Conventional to Stereotactic Body Radiation Therapy.

  2023cites this paper
• Some Like It Hot: The Value of Dose and Hot Spots in Lung Stereotactic Body Radiation Therapy.

  2023cites this paper
• Translational study for stereotactic body radiotherapy against non-small cell lung cancer, including oligometastases, considering cancer stem-like cells enable predicting clinical outcome from in vitro data.

  2023cites this paper
• An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer

  2023cites this paper
• Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery

  2023cites this paper
• Investigation of uncertainty in internal target volume definition for lung stereotactic body radiotherapy

  2023cites this paper
• Potential advantages of FDG‐PET radiomic feature map for target volume delineation in lung cancer radiotherapy

  2022cites this paper
• Effect of plan complexity on the dosimetry, delivery accuracy, and interplay effect in lung VMAT SBRT with 6 MV FFF beam

  2022cites this paper
• Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer

  2022cites this paper
• Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial

  2022cites this paper
• [Introduction of high-precision stereotactic body radiotherapy of lung tumors at Markusovszky Hospital].

  2022cites this paper
• Application of real-time MRI-guided linear accelerator in stereotactic ablative body radiotherapy for non-small cell lung cancer: one step forward to precise targeting

  2022cites this paper
• Improving the accuracy of motion quantification using area detector computed tomography for real-time tumor-tracking irradiation in stereotactic ablative radiotherapy.

  2022cites this paper
• Selection Strategy of Jaw Tracking in VMAT Planning for Lung SBRT

  2022cites this paper
• Setup accuracy and dose attenuation of a wooden immobilization system for lung stereotactic body radiotherapy

  2022cites this paper
• Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis

  2022cites this paper
• Research landscape and trends of lung cancer radiotherapy: A bibliometric analysis

  2022cites this paper
• Körperstereotaktische Bestrahlung im Vergleich zu moderner Chirurgie zur Behandlung des NSCLC im Stadium I

  2022cites this paper
• Improved biological dosimetric margin model for different PTV margins with stereotactic body radiation therapy in homogeneous and nonhomogeneous tumor regions

  2022cites this paper
• Prognosis of stage I non-small cell lung cancer patients aged ≥ 80 years who were considered medically operable but received best supportive care alone.

  2022cites this paper
• Accelerated Hypofractionated Radiotherapy for Centrally Located Lung Tumours Not Suitable for Stereotactic Body Radiotherapy or Chemoradiotherapy.

  2022cites this paper
• Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis

  2022cites this paper
• Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients

  2021cites this paper
• Reduction of Dosimetric-based Internal Target Volume Margin for Respiratory Motion in Lung Stereotactic Body Radiotherapy with Nonuniform Volume Prescription Method.

  2021cites this paper
• Cost‐effectiveness of carbon‐ion radiotherapy versus stereotactic body radiotherapy for non‐small‐cell lung cancer

  2021cites this paper
• Stereotactic body radiotherapy for apical lung tumors: Dosimetric analysis of the brachial plexus and preliminary clinical outcomes.

  2021cites this paper
• Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery – Commercial Medical Policy

  2021cites this paper
• Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease

  2021cites this paper
• American Radium Society™ Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer.

  2021cites this paper
• Early-Stage Non–Small-Cell Lung Cancer

  2021influential citation
• Zinc Oxide Nanoparticles Can Intervene in Radiation-Induced Senescence and Eradicate Residual Tumor Cells

  2021cites this paper
• MVCT versus kV‐CBCT for targets subject to respiratory motion: A phantom study

  2021cites this paper
• Computed tomography guided interstitial percutaneous high-dose-rate brachytherapy in the management of lung malignancies. A review of the literature.

  2021cites this paper
• Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery – Commercial Medical Policy

  2021cites this paper
• CT Appearance Pattern After Stereotactic Body Radiation Therapy Predicts Outcomes in Early-Stage Non-Small-Cell Lung Cancer

  2021cites this paper
• How to deal with the relationship between hypoxia and radiotherapy in the hypofractionated radiotherapy era

  2021cites this paper
• Variation of Tumor Volume During Moderate Hypo-Fractionated Stereotactic Body Radiation Therapy for Lung Cancer

  2021cites this paper
• Percutaneous local tumor ablation vs. stereotactic body radiotherapy for early-stage non-small cell lung cancer: a systematic review and meta-analysis

  2021cites this paper
• Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients

  2021cites this paper
• Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancer.

  2021cites this paper
• Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy

  2021cites this paper
• Lung Stereotactic Body Radiotherapy (SBRT) Using Spot-Scanning Proton Arc (SPArc) Therapy: A Feasibility Study

  2021cites this paper
• Cone beam computed tomography and image registration based on target area for stereotactic body radiation therapy of lung cancer

  2021cites this paper
• Stereotactic Body Radiotherapy of Lymph Node Oligometastases.

  2020cites this paper
• Current radiotherapy techniques in NSCLC: challenges and potential solutions

  2020cites this paper
• An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer.

  2020cites this paper
• Stereotactic body radiotherapy feasibility for patients with peripheral stage I lung cancer and poor pulmonary function.

  2020cites this paper
• Prognostic impact of solid tumor component diameter in early-stage non-small cell lung carcinoma treated with intensity-modulated fractionated radiotherapy: a retrospective analysis impact of solid tumor component diameter in NSCLC treated with IMRT

  2020cites this paper
• Radiation-Induced Secondary Cancer Risk Assessment in Patients With Lung Cancer After Stereotactic Body Radiotherapy Using the CyberKnife M6 System With Lung-Optimized Treatment

  2020cites this paper
• A COMPARATIVE STUDY OF 3D-CRT, IMRT AND VMAT TECHNIQUES IN THE TREATMENT OF LUNG CANCER USING STEREOTACTIC BODY RADIATION THERAPY

  2020cites this paper
• Assessment of biological dosimetric margin for stereotactic body radiation therapy

  2020cites this paper
• Stereotactic body radiation therapy for medically inoperable early-stage lung cancer: Tata Memorial Hospital perspective and practice recommendations

  2020influential citation
• Long Term Results of Single-Fraction Carbon-Ion Radiotherapy for Non-small Cell Lung Cancer

  2020cites this paper
• Ten-Year Experience of Stereotactic Body Radiotherapy at a Single Institution: Impact of Technological Development on the Outcome of Patients With Early Lung Cancer

  2020cites this paper
• Dosimetric evaluation of SBRT treatment plans of non-central lung tumours: clinical experience

  2020cites this paper
• Dose Prescription Methods in Stereotactic Body Radiotherapy for Small Peripheral Lung Tumors: Approaches Based on the Gross Tumor Volume Are Superior to Prescribing a Dose That Covers 95% of the Planning Target Volume

  2020cites this paper
• Determination of reproducibility of end-exhaled breath-holding in stereotactic body radiation therapy

  2020cites this paper
• New method for measurement of chest surface motion in lung cancer patients: Quantification using a technique of deformable image registration.

  2020cites this paper
• Evaluation of the robustness of 3-dimensional conformal technique with MLC position control into the planning target volume in stereotactic body radiotherapy for lung cancer.

  2020cites this paper
• Interobserver agreement between interpretations of acute changes after lung stereotactic body radiotherapy

  2020cites this paper
• Impact of target dose inhomogeneity on BED and EUD in lung SBRT

  2020cites this paper
• Alternatives to Surgery for Early-Stage Non-Small Cell Lung Cancer: Stereotactic Radiotherapy.

  2020cites this paper
• Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy

  2020cites this paper
• Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.

  2020cites this paper
• Effects of the recurrence pattern on patient survival following SABR for stage I lung cancer

  2020cites this paper
• Clinical Outcomes and Predictors of Lung Toxicity After Multiple Courses of Lung Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.

  2020cites this paper
• Dosimetric Comparison of Flattening Filter-Free Energies for Lung SBRT

  2019cites this paper
• Outcomes of gefitinib therapy for disease recurrence in medically inoperable stage I lung adenocarcinoma patients with active EGFR mutations receiving stereotactic body radiotherapy: a single-institute retrospective study

  2019cites this paper
• Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications

  2019cites this paper
• The PEMBRO-RT phase II randomized trial and the evolution of therapy for metastatic non-small cell lung cancer: a historical perspective.

  2019cites this paper
• Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)

  2019cites this paper
• Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review

  2019cites this paper
• Three-dimensional dose comparison of flattening filter (FF) and flattening filter-free (FFF) radiation therapy by using NIPAM gel dosimetry

  2019cites this paper
• Radiation Therapy in Non-small-Cell Lung Cancer

  2019cites this paper
• Stereotactic Body Radiation Therapy (SBRT) for Primary Lung Cancer

  2019cites this paper
• Stereotactic Body Radiotherapy for Lung Tumors: Basic Principles and Clinical Results

  2019cites this paper
• Stereotactic body radiation therapy for non-small cell lung cancer: A review

  2019cites this paper
• Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.

  2019cites this paper
• Should stereotactic body radiotherapy doses be adjusted according to tumor size in early-stage non-small-cell lung cancer? A Systematic Review and meta-analysis.

  2019cites this paper
• Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.

  2019cites this paper
• Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles

  2019cites this paper
• Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI

  2019cites this paper
• An in vitro study for the dosimetric and radiobiological validation of respiratory gating in conventional and hypofractionated radiotherapy of the lung: effect of dose, dose rate, and breathing pattern

  2019cites this paper
• Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

  2019cites this paper
• Sorption Detoxification as an Addition to Conventional Therapy of Acute Radiation Sickness and Iatrogenic Leukopenia

  2019cites this paper